Posters at MM2018

Posters at MM2018 2018-11-22T12:27:04+00:00


1 Compliance with local surgical antibiotic prophylaxis guidelines in the setting of a critical vancomycin shortage
2 In the age of ‘Dr Google’, are medicines information services still relevant?
3 Time for teamwork: an inpatient/outpatient pharmacist deprescribing initiative for hemodialysis patients
4 Sudden shock: Rituximab desensitisation after an anaphylactoid reaction
5 Venous thromboembolism risk documentation, prescribing rates and appropriateness of prophylaxis: a prospective, multisite audit
6 The journey from ICU – pharmacists needed more than ever in the digital world
7 Medicine information provided to inpatients – are we doing what patients want?
8 Resistant phantom limb pain: treatment without a leg to stand on
9 Oral liquid opioids: the benefits of moving from bottles to unit dose pods
10 Apixaban dosing guidelines in atrial fibrillation: implementation in the real world
11 Potentially life threatening oral methotrexate dosing errors reported in NSW hospitals
12 Beyond supply of medications: an audit identifying the additional clinical benefits of ward pharmacy technicians
13 Increased risk of rejection following itraconazole vs nebulised amphotericin fungal prophylaxis after heart transplant
14 Better together: a multi-site drug use evaluation of anticoagulant prescribing in Queensland public hospitals
15 For the first time – Eculizumab for treatment of chronic antibody-mediated rejection in cardiac transplant
16 The development of national guidelines for the safe prescribing, dispensing and administration of cancer therapy
17 Flucytosine for treatment of Cryptococcus neoformans meningitis in an obese patient and therapeutic drug monitoring
18 Tick tock! Stop the clot: VTE risk assessments in an older persons mental health ward
19 To cease or not to cease? That is the question. Developing perioperative medication management guidelines.
21 Pharmacist-led multidisciplinary compilation of peri-operative medication management guideline in response to local hospital needs
22 Time efficiencies with the paediatric assessment unit (PAU) – a pharmacy perspective
23 H. Pylori eradication: a therapy for immune thrombocytopenic purpura?
24 Evaluation of glycaemic control during treatment with insulin infusions in critically ill patients
26 Leech therapy: a ‘handy’ way to anticoagulate
27 Pharmacokinetic comparison of two neonatal gentamicin regimens: a quasi-experimental study
29 Prescribing cascades and their effect on patients; investigating inappropriate prescribing in people with Parkinson’s
30 Preventing re-admissions through medication review
31 Modified palifermin schedule, administered for 3 doses, minimises mucositis in stem cell transplantation patients
32 Evaluation of the emetogenicity of intravenous Erwinia asparaginase at a tertiary teaching hospital’s oncology centre
33 Sterility testing of defibrotide syringes compounded in an aseptic production unit
34 A review of icatibant use; the bad, the good and the ace
35 A review of aspirin administration in acute ischaemic stroke within 48 hours of admission
36 Can we engage surgeons in antimicrobial stewardship? Experience from weekly surgical AMS rounds
37 Automated screening of look-alike, sound-alike medicine names for safety
38 It’s time to try colistin
39 Assessing the impact and feasibility of pharmacist attendance on post-take ward rounds
40 How do Australian hospital pharmacists prioritise high-risk patients? A focus group and national survey study
41 Outcomes from Pegfilgrastim use in adult acute myeloid leukaemia (AML) and acute lymphoblastic leukaemia (ALL)
42 Azithromycin for everyone: an audit of azithromycin use within the emergency department
43 Therapeutic drug monitoring: are we getting it right and optimizing therapy?
44 Evaluation of an obstetric subcutaneous insulin chart in women with gestational diabetes
46 Pilot and validation of the shred learning styles questionnaire for patient education
47 Characterizing causes of medication related harm in a tertiary pediatric hospital using a trigger tool
49 Antibiotic management of community-acquired aspiration pneumonia in the ICU: how much piperacillin/tazobactam is too much?
50 It’s time to optimise dosing of unfractionated heparin in obese patients
51 Utilising pre-defined oral switch criteria to identify missed intravenous to oral antibiotic switch opportunities
52 Direct oral anticoagulant monitoring: real world utilisation of rivaroxaban plasma level monitoring
54 Making nursing in-services more effective – it’s time!
55 A retrospective analysis of iv amoxicillin-clavulanate prescribing in patients with appendicitis: a tertiary hospital experience
56 PICC-ing the problem – optimizing antibiotic delivery via elastomeric infusors in paediatric cystic fibrosis patients
57 A complicated case of cryptococcal pneumonia in a renal transplant patient
58 Pharmacist-led therapeutic drug monitoring: impact of education and competency assessment on paediatric patient care
59 User testing to examine patient understanding of pharmacy generated medication labels
60 It’s time hospital pharmacists collaborate to close the gap on indigenous smoking
61 Hit Antiphospholipid Syndrome with rivaroxaban? Not so fast.
64 Concomitant clozapine and chemotherapy in a patient with schizophrenia and newly diagnosed bladder cancer
65 Severe hypophosphataemia induced by intravenous iron: role of the pharmacist in searching for alternate treatments
66 Therapeutic enoxaparin anti-factor Xa monitoring: are we doing enough? A retrospective analysis.
67 Mycophenolate mofetil: a novel treatment for cryptogenic organising pneumonia
68 A rare case of valproate induced encephalopathy
69 Assessing the safety of manufacturer provided measuring devices for oral dosing in a paediatric setting
70 Let’s not take our own sweet time managing perioperative blood glucose levels (BGLs)
71 Once-off and forgotten? Assessing communication of inpatient medication therapy to general practitioners on discharge.
73 A tale of two hearts: cardiac arrest post administration of misoprostol
74 Parkinson’s Disease and time-critical medications: patient experience and staff awareness
75 Colecalciferol initiation post-minimal trauma fracture
76 Case series; hypocalcaemia requiring hospitalisation following administration of denosumab in chronic kidney disease (CKD) patients
77 Successful treatment of Addisons Disease with continuous subcutaneous hydrocortisone via insulin pump
78 Swallowing the costs: timely switching of parenteral to oral therapy
79 Sodium nitrite, not your cure-all remedy
80 Tobramycin dosing in adults with cystic fibrosis: balancing safety, efficacy and tolerability
81 Clinical experience with U-500 concentrated insulin: efficacy and safety
82 Evidence for antipsychotic polypharmacy in refractory schizophrenia: a literature review
83 Duloxetine and sexual disinhibition: an unrecognised side effect
84 Stop the clot: evaluation of Apixaban use
85 Clinical pharmacist involvement in the management of disseminated nocardiosis
86 Intravenous (IV) sildenafil for PPHN – practice implications for the neonatal pharmacist
87 Comparison of oral vs topical/intravenous tranexamic acid in total knee replacements
88 Psychotropic use in patients with dementia in the geriatric evaluation medicine inpatient setting
89 Green or purple pen? Does it really matter? Are we wasting our time?
90 An evaluation of the management of asymptomatic hypertension focusing on the use of glyceryl-trinitrate patches
91 Asparaginase precipitation with chemoclave® during sterile manufacturing
92 In your best Entrests?: a case study on the use of Entresto in heart failure
93 Hydromorphone, are we doing it right? (a drug use evaluation of hydromorphone for hospital inpatients)
94 Vancomycin dose conversion from intermittent to continuous infusion94 Vancomycin dose conversion from intermittent to continuous infusion
96 Changeover from Sporanox® to Lozanoc® in adults with cystic fibrosis
98 It’s time to review: contribution of prescription medications to emergency department overdose presentations
99 The use of Ketoconazole in Sarcoidosis induced Hypercalcaemia
100 Ondansetron induced acute chorea with hyperthermia in an obstetric patient
101 Off-label use of Interferon Gamma-1b for osteopetrosis: a case report
102 Don’t rush to crush: audit of routine practices for patients with swallowing difficulties
104 Rituximab – a compounding cost analysis
105 Impact of the pharmacy board guidance on sterile injectable medicines on a hospital compounding unit
106 Say yes to the stress: prevalence of emergency steroid stress plans
109 Management of vancomycin in an acute hospital – pharmacists’ impact on therapeutic drug monitoring (vancman)
110 Vancomycin and piperacillin-tazobactam combination therapy – evaluating the risk of acute kidney injury (sub-analysis vancman)
111 Cost and time impact of cancer centre patient screening model
112 Oral antibiotics in a surgical site infection prevention bundle of care for colorectal surgery
113 Helicobacter pylori salvage therapies: evaluating outcomes of outpatient regimens utilised at an Australian hospital
114 You got to have a nerve to say ‘NO’ to opioids!
115 Pharmacist-initiated management of a suspected case of risperidone-induced neuroleptic malignant syndrome in an aged-care resident
117 It’s time to optimise medications – a patient-centred approach
118 The evaluation of hyperhydration for high dose melphalan in stem cell transplantation
119 Retrospective audit of critical missed medication doses before electronic medication administration implementation
120 Opioid related adverse events (ORADEs) – using data to facilitate pharmacist interventions
121 The truth is out there: a case report of flucytosine toxicity in a haemodialysis patient
122 Adrenal insufficiency? Fear not! – a step-by-step checklist for pharmacists
123 Can you teach old drugs new tricks? A case of nitazoxanide for human parainfluenza 3
124 Salvage of venous congested free flaps: it’s TBA for subcutaneous tPA
125 Dazed and confused: variability and consumer feedback on the discharge instructions of high-risk ‘pincha’ medications
126 Case study: pharmacological management of aggression and impulse control in Huntington’s Disease
127 Hyperglycaemia post-kidney transplantation: blood glucose monitoring and insulin prescribing habits
129 Total intended antibiotic delivery related to concentration affecting flowrate of elastomeric devices used in OPAT
130 Reducing paediatric medication errors and hospital stay: a systematic review of clinical pharmacist interventions
131 Time under pressure: an assessment of the Baxter Elastomeric (LV-10) infusor pump under hyperbaric conditions
132 Vancomycin dose management in neonatal intensive care units (NICU)
133 Bisphosphonates in kidney transplant patients: time for a holiday?
134 Opioid prescribing on hospital discharge – “we can no longer oxycondone poor prescribing”
135 Expanding the outreach pharmacist role: delivering phone based medication education to cardiac clients
138 Clinical decision making in the setting of rare and unexpected adverse events
139 Sodium thiosulfate 25% topical cream in treatment of dystrophic calcinosis cutis – case report
140 Deprescribing anti-hypertensive medications in the elderly – room to move
141 The pharmacist contribution to a pilot counselling service for patients starting oral anticancer drugs (OADs)
142 Proton pump inhibitor use and chronic kidney disease – a clinical audit
143 Development of an opioid safety strategy to minimise opioid related adverse events (ORADEs)
144 Psychotropic versus chemotherapeutic drug interaction tool: an essential time-saving resource for clinicians
145 MET calls; does pharmacy answer? Pharmacist contribution to patient care around time of Met call
146 Prazosin – a dream come true for PTSD nightmares
148 Improving identification and management of patients in or at risk of alcohol withdrawal
149 Advanced technician in a specialised bone marrow transplant clinic
150 Calciphylaxis – a case study
152 Clinical audit of urinary tract infections in renal transplant patients
153 Amiodarone initiation and baseline monitoring at a large tertiary institution
155 Appropriate use of medicines: the role of dose information on dispensed prescription medicine labels
156 Evidence for a standardised approach to naming medicines on dispensed labelling
158 The great escape! Using an “escape room” game for interactive clinical education and team building
159 Management of human T-cell lymphotropic virus type-1-associated adult T-cell leukaemia: pharmacist involvement in rare malignancies
160 Medication management of newly diagnosed acute promyelocytic leukaemia
161 Prescriber follow-up of pharmacist clinical interventions in an Australian teaching hospital
162 Patients with residual chemotherapy when using 5-FU + saline elastomeric devices
163 A retrospective audit of venous thromboembolism (VTE) prophylaxis prescribing post-caesarean section
164 Stiff luck: peri-operative medication management in Parkinson’s Disease
165 Vancomycin enema? A treatment option for clostridium difficile localised in a rectal stump
166 Clozapine levels: navigating infection and interactions in a treatment refractory patient
167 A prospective analysis of inpatient hypoglycaemic events at an acute public hospital
168 Venous thromboembolism prophylaxis: a clinical decision support and prescribing tool for electronic medication management
169 POPI on surgical wards
170 Genesis of specialist paediatric outpatient pharmacy clinics in a tertiary hospital – going back for seconds
171 Trastuzumab/anthracycline induced cardiomyopathy – missed opportunity for early diagnosis and treatment
172 Sleeping beauty: optimising communication of suspected obstructive sleep apnoea to GPs in opioid-treated, post-operative patients
173 Impact of timely medication review in the emergency department
174 Enhancing patient care with multidisciplinary rounds in ICU
175 Contraceptive planning for postnatal women with substance abuse disorders
176 Sustaining medication safety through restrictions on telephone orders
177 Medication-related adverse events from the emergency medicine events register (
178 Pharmacist-led prescribing and monitoring of antimicrobials
179 To continue or not to continue perioperative opioid substitution therapy, that is the question!
180 Evaluating short and long-term outcomes of hospital led deprescribing in the elderly
181 Implementing and evaluating a multidisciplinary antimicrobial stewardship ward round in a rural hospital
182 Validating a proposed state-wide medication incident classification system
183 Development of a medication incident classification system to standardise reporting in clinical practice
184 Partnering with consumers to assess and improve satisfaction and understanding of medicine lists
185 Can low-dose methotrexate cause seizures?
186 The type and nature of pharmacist recommendations in a healthy ageing clinic
187 High vancomycin doses required for critically ill Australian indigenous patients
188 The role of linezolid therapeutic drug monitoring (TDM) in multi-drug resistant tuberculosis (MDR-TB)
189 Ultrarapid iron polymaltose infusion for iron deficiency anaemia (UltraRIIPH): a pilot safety study
190 Long-term opioid use in hepatic impairment is associated with adverse outcomes
191 Fluid and potassium replacement during amphotericin treatment: when just a little bit won’t do
192 Evaluation of nature, documentation and communication of coded adverse drug reactions
193 Assessing antimicrobial prescribing in small Australian hospitals: the patient journey
194 Prescriber adherence to management guidelines and patient adherence to treatment recommendations in COPD
195 Plasmaphoresis/exchange (plex) and levetiracetam dosing – are first principles accurate?
196 Metabolic bone disease of prematurity – a new protocol for detection, diagnosis and treatment
197 Medication-related emergency department re-presentations: characterising the medication-related problems and examining the pharmacist’s role
199 Analgesic stewardship: how long will it take you to get on board?
200 Measuring the efficiency and effectiveness of team-based pharmacy technicians: a time and motion study
201 Breaking into prison
202 Antimicrobial dosing in critical care: a pragmatic dosing guideline
203 An audit of the documentation of new oral anticoagulants
204 Post-operative opioid prescribing trends on discharge: a retrospective audit
206 The hype about hyperthermic intraperitoneal chemotherapy
207 The potential impact of pharmacist intervention on re-presentation and re-admission rates from high turnover units
208 Off-label use of calcitonin in the treatment of phantom limb pain: a mini case series
209 Empirical antimicrobial therapy for urinary tract infections in the emergency department: a retrospective audit

Digital / IT Health

210 Transfer medication reconciliation – lost in translation!
211 Optimising an eMeds system using a community of practice approach to deliver patient safety benefits
213 The impact of hospital-wide digitalisation on medication prescribing for ICU discharges
214 Heparin titration is hard: let the app do the work!
215 Less painful alerts – targeted alerts for the safe use of parecoxib and postoperative NSAIDs
216 It’s time to set ‘sights’ on being the same as everyone else; uniqueness is overrated
217 Acute behavioural disturbance management in an electronic medication record; is it safer?
218 WhatsApp with antimicrobial stewardship in NSW?: evaluation of social media as a resource
220 It’s time to re-design safe prescribing education for digital hospitals!
221 There’s an app for that: automating antimicrobial stewardship reports to stretch limited resources
222 Eyes in the sky: remote proactive surveillance supporting multi-site medication safety during digital transformation
223 Hospital wide communication and assigning tasks for patient care – there’s an app for that!
225 Time-and-motion study of imprest supply times before and after Pyxis implementation in four emergency departments
226 Where’s WALL-E™: where do robots really impact hospital pharmacy dispensaries?
229 Digital surveillance to improve clozapine management in non-psychiatric wards
230 New state-wide eLearning modules to improve doctors’ knowledge of venous thromboembolism prevention
231 Empowering patients to manage medications: incorporating medication management strategies into an e-Learning module
233 Improving chemotherapy quality and safety – VicTAG chemotherapy audit toolkit
234 Identifying effective prescribing alerts to include in an electronic medication management system
235 Keeping smart infusion pumps (SIPs) “smart”: dataset maintenance, continuous quality improvement (CQI) & compliance
236 eHealth: how does it weigh in?
239 Use of dynamic ward lists to assist prioritisation of pharmacist services
240 It’s time to search smarter: using URL tricks to search faster
241 Timely access to medication related clinical incident data for the multidisciplinary clinical workforce
242 A spoonful of eMEDs helps the medicine go down: eMEDs/workflow synergy improves discharge summary accuracy


243 It’s time to simplify hazardous drugs management: leading the implementation of a district-wide easy-to-use system
245 Time to increase staff flexibility through standardised role descriptions
246 It’s time to review WhatsApp™
247 Monitoring chemotherapy prescribing compliance in the post inquiry era
248 Pharmacists leading the fight against venous thromboembolism
249 Let it go! Assessing pharmacist interventions during reconciliation of general and specialty medicine discharge prescriptions
250 It’s time to advance technician roles and save on medication wastage
251 A cast of seventeen – a pharmacy and nursing collaborative production
252 Incorporation of a theme-based research (TBR) model into a pharmacy departmental research program
253 Pharmacy technicians’ perception of strategies to mitigate repetitive strain injury risks associated with sterile compounding

Workforce / practitioner development

254 Impact of the addition of a pharmacy assistant to the stroke clinical pharmacy services
255 Standardizing the prescribing, dispensing and labeling of etoposide phosphate to avoid dosing errors
256 Education of a nation – establishing a needs-based education approach
257 Barriers and benefits – pharmacist prescribers’ views of the prescribing role
258 Increasing production and reducing waste – just in time versus ready on time
259 Medication trolley safety on the rehabilitation unit: pharmacy assistant led interventions
263 A new approach for pharmacy student placements: the student-led ward
264 Abstract time: assistant abstract development coaching to share innovation in patient care
265 Implementation of an immunisation pharmacist during a shortage of influenza vaccine
266 Innovative new career opportunity: medication review service for clients of community mental health clinics
267 Highlighting the need for emergency department resuscitation pharmacists
268 Medication administration evaluation and feedback tool: intra-rater and inter-rater reliability using simulation
269 Improving the delivery and documentation of an after-hours on-call pharmacy service
270 Making medication safety great again: an interactive drop-in session for nurses
272 Is our money where our mouth is? Do action plans get actioned?
273 Advanced pharmacy assistants taking best possible medication histories to enable pharmacy’s best possible clinical service
274 Residency leading the way
275 Prescribing trends of opioids in children post-tonsillectomy
277 It’s time to focus on weight management during cancer treatment – a team approach!
278 Medication mishaps: when misery brings mastery
280 An early career hospital pharmacist education initiative – case-based clinical discussion group
281 Learning plans: a state-wide approach to support teaching and learning for the pharmacy workforce
282 From assessment of competence to entrustable professional activities (EPAs)
283 What factors impact Australian pharmacists’ disaster preparedness?
284 Pharmacy automation: measuring the effect of ward-based automation on inpatient dispensary services
285 A novel hospital pharmacist role working with Aboriginal & Torres Strait Islander cardiac patients
286 The impact of including a pharmacy assistant (PA) in the pharmacy pre-admission clinic (PAC)
287 A multi-hospital Victorian collaboration to develop a standardised technician role expansion framework
288 Improving access to acute stroke trials using automated dispensing cabinet
289 It’s time to upskill: Cardiac Arrest Boxes Management, a new role for pharmacy technicians
290 It’s time for self-reflection: how do we manage conflict?
291 Optimising discharge services for haematopoietic stem cell transplant patients by expanding the oncology technician role
292 Establishment of a workplace-based experiential clinical pharmacy training program in Australia for Chinese pharmacists
293 Piloting an education package to support nursing and midwifery staff in medication reconciliation processes
294 Development of a clinical informatics rotation during a foundation residency program
295 An innovative recruitment strategy: “mini-interviews” as a component of the pharmacy resident appointment process
296 Assessing pharmacists’ antimicrobial knowledge and their perceived effectiveness in challenging suboptimal prescribing in hospital
298 We’re bringing manufacturing back: reabsorption of antibiotic infusor manufacturing from an external compounder
299 Following clozapine into the community: review of clozapine monitoring in community clinics
300 Cardiac meds, dental dreads: cariogenic potential of oral-liquid medications
301 The effect of changing the model of service provision on clinical pharmacists
302 Collaborative doctor – pharmacist prescribing in the emergency department and admissions unit
303 Development and evaluation of a residency program in medicines information
305 Audit of Calderdale framework implementation at a leading tertiary hospital pharmacy
306 Time to think small! Evaluation of feedback from paediatric experiential hospital placements
307 Introducing the patient flow pharmacist